A left internal mammary artery takedown robot-assisted heart procedure is the latest milestone for an Indian robotics company.

Nichelle Nichols, who played Lt. Uhura in Star Trek, died from undiagnosed and untreated heart failure after seeking medical treatment.

The LivIQ leadless pacemaker offers a single-device solution designed to deliver AV synchrony through far-field sensing. 

While AI analytics has greatly increased the ease of access to vast amounts of cardiology data, action is still required to make it useful.
 

Moving X-ray images can help evaluate pulmonary regurgitation in Tetralogy of Fallot patients.

The decision clears the way for Hikma Pharmaceuticals' sale of icosapent ethyl in the U.S. market.

The Edwards Lifesciences Triformis Resilia is the first dedicated surgical tricuspid valve on the market cleared with data from off-label use of mitral valves.

FFR-CT literature has reached a state of maturity where experts can comfortably start to provide guidelines to the wider community. 

Robert Hawkins, MD, discussed an updated risk calculator—and the latest data on SAVR after TAVR—for a new video interview with Cardiovascular Business.

The numbers from the Georgetown University McCourt School of Public Policy’s Center for Children and Families, a nonprofit academic research group that is drawing from recent enrollment data gathered by state governments.

The American Hospital Association is out with a set of strategies for making healthcare more affordable—not only within hospitals but also across U.S. healthcare as a whole. The gameplan walks hospital leaders through a number of actionable and achievable aims to which they can contribute.

When Mayo Clinic and Microsoft announced last week that they’re partnering to develop a frontier AI model for healthcare, observers could see where Mayo’s expertise in advanced digital medicine would interest Microsoft. The Big Tech behemoth has not been coy about its healthcare ambitions. 

The buyout, announced last summer, drew the attention of federal regulators at the Federal Trade Commission, concerned that competition for ambulatory surgery services would be stifled by the merger. To appease the agency, Ascension has agreed to divest from some centers previously owned by Amsurg.

The saved time does not come at the expense of image quality, with the exam actually increasing lesion detection instead. 

The app offers detailed guidance on how to treat adverse reactions to both iodine- and gadolinium-based contrast media.